Influenza vaccine quadrivalent (Protein Sciences Corporation)

N/A

Report date: 2025/06/16 20:00:38

Base Information

Drug NameInfluenza vaccine quadrivalent (Protein Sciences Corporation)
Drug Alias Name流感病毒疫苗四价 - Protein SciencesFluBlok-QSeasonal quadrivalent influenza vaccineQuadrivalent recombinant influenza vaccine seasonalFlublok Quadrivalent +[7] 
ClassificationVaccines > Development/production technology > Genetically engineered subunit vaccineVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/10/07
Country/TerritoryCzechiaUnited StatesPoland +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesProtein Sciences Corporation
China Registration ClassN/A

Develop Information

Active CompaniesSanofi PasteurSanofi Winthrop Industrie SA
Inactive CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Protein Sciences CorporationShenzhen Sanofi Pasteur Biological Products Co Ltd
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB
Related LinksN/A